NO20072588L - Ernaeringssupplement og anvendelse derav - Google Patents

Ernaeringssupplement og anvendelse derav

Info

Publication number
NO20072588L
NO20072588L NO20072588A NO20072588A NO20072588L NO 20072588 L NO20072588 L NO 20072588L NO 20072588 A NO20072588 A NO 20072588A NO 20072588 A NO20072588 A NO 20072588A NO 20072588 L NO20072588 L NO 20072588L
Authority
NO
Norway
Prior art keywords
muscle
relates
recovery
performance
nutritional supplement
Prior art date
Application number
NO20072588A
Other languages
English (en)
Inventor
Pentti Hietala
Tuomo Karila
Timo Seppala
Karim Tahtivuori
Original Assignee
Elmomed Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elmomed Ltd Oy filed Critical Elmomed Ltd Oy
Publication of NO20072588L publication Critical patent/NO20072588L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Abstract

Den foreliggende oppfinnelse angår generelt forsterking og restitusjon av muskelyteevne i en stresstilstand indusert av fysisk trening, sykdom eller traumer. Mer spesielt angår oppfinnelsen bruk av DL-a-hydroksy-isokapronsyre (HICA) til å forbedre muskelyteevne og for å tilveiebringe mer effektiv muskelrestitusjon etter fysisk eller traumatisk stress. Den foreliggende oppfinnelse angår også midler til å øke kroppsmassen, inkludert muskelmasse og spesielt fettfri kroppsmasse. Særlig angår oppfinnelsen et ernæringssupplement og anvendelse derav for forsterket restitusjon og/eller yteevne av musklene. Oppfinnelsen angår videre en fremgangsmåte til å forbedre muskelyteevne i og muskelrestitusjon fra en stresstilstand indusert av fysisk trening, sykdom eller traumer.
NO20072588A 2004-10-21 2007-05-21 Ernaeringssupplement og anvendelse derav NO20072588L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20045395A FI20045395A (fi) 2004-10-21 2004-10-21 Ravintoainelisä ja sen käyttö
PCT/FI2005/050365 WO2006042909A1 (en) 2004-10-21 2005-10-20 Nutrient supplement and use of the same

Publications (1)

Publication Number Publication Date
NO20072588L true NO20072588L (no) 2007-05-21

Family

ID=33306113

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072588A NO20072588L (no) 2004-10-21 2007-05-21 Ernaeringssupplement og anvendelse derav

Country Status (7)

Country Link
US (1) US20080108698A1 (no)
EP (1) EP1811985A4 (no)
AU (1) AU2005296915A1 (no)
CA (1) CA2595212A1 (no)
FI (1) FI20045395A (no)
NO (1) NO20072588L (no)
WO (1) WO2006042909A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009073944A1 (en) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. USE OF PYRIDOXINE α-HYDROXYISOCAPROATE TO REDUCE METABOLIC ACIDOSIS AND AMMONIA ACCUMULATION
US8173181B2 (en) 2009-11-09 2012-05-08 Bio-Engineered Supplements & Nutrition, Inc. Method and composition for improved anabolism
BR112013026706A2 (pt) * 2011-04-18 2016-12-27 Nestec Sa composições nutricionais compreendendo ácido alfa-hidroxi-isocaproico
US20130018102A1 (en) * 2011-07-14 2013-01-17 Maximum Human Performance, Llc Nutritional supplement for the enhancement of muscle performance and recovery

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1444621A (en) * 1973-04-30 1976-08-04 Walser M Composition for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy-acid analogues of amino acids
GB1511302A (en) * 1974-04-15 1978-05-17 Univ Johns Hopkins Pharmaceutical compositions comprising amino acid analogues
US4677121A (en) * 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
SE8803144L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Energisubstrat
SE8803142L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Nya energisubstrat
AU702561B2 (en) * 1995-06-21 1999-02-25 Oy Extracta Ltd. Use of hydroxy acid or a product containing the same and a product made thereof
JP4444375B2 (ja) * 1997-03-14 2010-03-31 スミスクライン・ビーチャム・コーポレイション 新規キノリン−およびナフタレンカルボキサミド、医薬組成物およびカルパインの阻害方法
AU1409299A (en) * 1997-11-13 1999-06-07 University Of Florida Use of ketoacids together with amino acids for enhancing muscle performance and recovery from fatigue
US6206835B1 (en) * 1999-03-24 2001-03-27 The B. F. Goodrich Company Remotely interrogated diagnostic implant device with electrically passive sensor

Also Published As

Publication number Publication date
WO2006042909A1 (en) 2006-04-27
EP1811985A1 (en) 2007-08-01
AU2005296915A1 (en) 2006-04-27
EP1811985A4 (en) 2010-09-08
US20080108698A1 (en) 2008-05-08
CA2595212A1 (en) 2006-04-27
FI20045395A (fi) 2006-04-22
FI20045395A0 (fi) 2004-10-21

Similar Documents

Publication Publication Date Title
CY1116665T1 (el) Χρηση παραγωγων του ινδολοξικου οξεος που αυξανουν το επιπεδο ορου του παραγοντα igf-1 για την παρασκευη μιας θεραπευτικης συνθεσης για τη θεραπεια διαφορων νοσων
HK1084404A1 (en) Muteins of tear lipocalin
NO20072588L (no) Ernaeringssupplement og anvendelse derav
NO20062104L (no) Kombinasjonsterapi for HCV-infeksjon
WO2008135038A3 (de) Diagnose und risikostratifizierung mittels nt-proet-1
IN2012DN04085A (no)
MX2023000804A (es) Peptidos para usarse en la promocion del transporte de glucosa.
NO20070351L (no) Materialer og fremgangsmater for forbedring av skalldyrhelse, -immunitet og -vekst
WO2007081454A3 (en) Methods and apparatus for selecting intra-aortic balloon deflation timing
GB2429711A (en) Heart and skeletal muscle inflammation (HSMI) virus
UA35209U (ru) Способ продления жизни человека
WO2005077397A3 (en) Methods and compositions for treating vascular diseases
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
DE602004022416D1 (de) Verfahren zur herstellung von inaktiven ballistischen übungselementen und durch das verfahren hergestelltes inaktives ballistisches element
DK1758609T3 (da) Vaccine mod HPV 16 og HPV 18 og mindst en anden HPV-type udvalgt blandt HPV 31, 45 eller 52
WO2006057755A3 (en) Compositions containing cotinus coggygria extract and use thereof on mucosal tissues
ATE474046T1 (de) Vasopressin bindende l-nukleinsäure
WO2007120555A3 (en) Assessment of heart failure risk using genetic assessment of g-protein beta-3 subunit polymorphism
MX2008014606A (es) Confites congelados.
DE60336063D1 (de) Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren
WO2005020898A8 (en) Methods of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i)
White Restorer of the World: the Roman emperor Aurelian
WO2006061418A3 (en) Methods and agents useful in treating conditions characterized by mucus hyperproduction/hypersecretion
JP2010070463A5 (no)
CN205287454U (zh) 手指及手腕伸肌训练器

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application